摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(tert-butylthio)cyclohexylamine | 68597-76-2

中文名称
——
中文别名
——
英文名称
N-(tert-butylthio)cyclohexylamine
英文别名
2-methyl-propane-2-sulfenic acid cyclohexylamide;2-Methyl-propan-2-sulfensaeure-cyclohexylamid;S-tert-Butyl-N-cyclohexyl-thiohydroxylamin;N-tert-butylsulfanylcyclohexanamine
N-(tert-butylthio)cyclohexylamine化学式
CAS
68597-76-2
化学式
C10H21NS
mdl
——
分子量
187.349
InChiKey
HCIFKZSNFFOARH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    1,1-dimethylethanesulfenyl chloride环己胺乙醚 为溶剂, 反应 1.0h, 以30%的产率得到N-(tert-butylthio)cyclohexylamine
    参考文献:
    名称:
    N-烷基-N-(烷硫基)氨基的电子自旋共振研究
    摘要:
    DOI:
    10.1021/j100241a020
点击查看最新优质反应信息

文献信息

  • AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONIST ACTIVITY
    申请人:SHIONOGI & CO., LTD.
    公开号:EP2017261A1
    公开(公告)日:2009-01-21
    This invention provides a compound of the formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted lower alkyl, Y is -S(O)n- wherein n is 1 or 2, or -CO-, R2 is hydrogen or lower alkyl, R7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
    本发明提供了一种式 (I) 的化合物: 其药学上可接受的盐或溶液、 其中 R1 是任选取代的低级烷基、 Y是-S(O)n- 其中n是1或2,或-CO-、 R2 是氢或低级烷基 R7 是氢或低级烷基 X 是低级烯烃、低级烯烃、芳烃、环烷烃或类似物,以及 Z 是低级烷基、任选取代的碳环烷基、任选取代的杂环烷基或类似物。
  • AMINE DERIVATIVE HAVING NPY Y5 RECEPTOR ANTAGONIST ACTIVITY AND USE THEREOF
    申请人:Shionogi&Co., Ltd.
    公开号:EP2221051A1
    公开(公告)日:2010-08-25
    This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I); a pharmaceutically acceptable salt or solvate thereof, wherein R1 is optionally substituted lower alkyl, Y is -S(O)n- wherein n is 1 or 2, or -CO-, R2 is hydrogen or lower alkyl, R7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.
    本发明提供了一种包含式(I)化合物的厌食或抗肥胖组合物; 其药学上可接受的盐或溶液、 其中 R1 是任选取代的低级烷基、 Y 是-S(O)n-,其中 n 是 1 或 2,或-CO-、 R2 是氢或低级烷基 R7 是氢或低级烷基 X 是低级烯烃、低级烯烃、芳烃、环烷烃或类似物,以及 Z 是低级烷基、任选取代的碳环烷基、任选取代的杂环烷基或类似物。
  • Production of sulfenamides
    申请人:PHILLIPS PETROLEUM CO
    公开号:US02520400A1
    公开(公告)日:1950-08-29
  • NPYY5 ANTAGONISTS
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1249233B9
    公开(公告)日:2009-08-05
  • Electron spin resonance study of N-alkyl-N-(alkylthio)aminyl radicals
    作者:Yozo Miura、Hidetsugu Asada、Masayoshi Kinoshita、Katsuhisa Ohta
    DOI:10.1021/j100241a020
    日期:1983.9
查看更多

同类化合物

甲磺酸 N,N-二甲基-2,2-二甲基乙烷次磺酰胺 2-甲基异噻唑烷 2-氰基-2-五氟苯基丁酸乙酯 N-methyl-N-tert.-octylthiomethylamine hydrochloride N-methyl-N-ethylthiomethylamine hydrochloride N-methyl-N-isopropylthiomethylamine hydrochloride perfluoro-2-methyl-1-cyclopenten-N,N-diethylsulfenamide 2-β-hydroxyethylthioethylamine hydrochloride 2-Amino-aethan-1-sulfensaeure N,N'-bis(1,1,1,2,3,3,3-heptafluoropropan-2-ylsulfanyl)-N,N'-dimethylethane-1,2-diamine N-[(1,1,2,2-Tetrachloroethyl)sulfanyl]methanamine 2-methyl-3,6-dihydro-1,2-thiazine N,N-dibutyl-hexane-1-sulfenamide N-[2-(dimethylaminosulfanyl)ethylsulfanyl]-N-methylmethanamine N-(butylthio)-tert-butylamine 1,1-dimethyl-ethanesulfenic acid dibutylamide N-Methylmethansulfenamid N-(tert-butylthio)ethylamine N-(tert-butylthio)butylamine N-(tert-butylthio)cyclohexylamine N,N-Dimethyl-2-chlortetrafluoraethansulfenamid N-<2-(Methlthio)-ethylthio>-dimethylamin N,N-Di-n-butylmethansulphenamid nonafluoro-n-butanesulfenic acid N-(Chlormethylthio)diethylamin N-[2-[2-[ethyl(methyl)amino]sulfanylethoxy]ethylsulfanyl]-N-methylethanamine N-ethyl-N-methyl-hexanesulfenamide N-(tert-butylthio)methylamine 2-isopropyl-4,5-dimethyl-3,6-dihydro-1,2-thiazine N-(Chlormethylthio)dimethylamin N-[1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propan-2-yl]sulfanyl-N-methylmethanamine N-(Propan-2-yl)-N-(propylsulfanyl)propan-2-amine N-Ethyl-N-(propylsulfanyl)ethanamine N,N-dipropyl-propane-1-sulfenamide 2-methyl-N-(2-methylpropyl)-N-propylsulfanylpropan-1-amine N-Butylpropanesulfenamide N,N-diethylmethanesulfenamide 1-Chlor-N-(1,1,3,3-tetramethylbutyl)-1,1-bis(trifluormethyl)methansulfenamid N-(1-Adamantyl)-1-chlor-1,1-bis(trifluormethyl)methansulfenamid N-(tert-butylthio)isopropylamine 4-Propyl-1,3,4-oxathiazinane (5Z)-3-(methylsulfanylamino)-5-[(Z)-prop-1-enyl]nona-1,5-dien-2-olate N-ethyl-N-ethylsulfanyl-2-(methylideneamino)ethenamine 4,4-Dichloro-3-octylidene-1,2-thiazolidine N,2-dimethyl-N-methylsulfanylpentan-1-amine (1R,2R)-1,2-bis(hydroxysulfanyl)ethane-1,2-diol 2-(Methylaminosulfanyl)ethanamine 2-Ethyl-3-hydroxysulfanylbutan-1-ol 2-ethyl-2-methyl-N-(5-methylhexyl)-N-methylsulfanylhexan-1-amine